Co-Diagnostics's total assets for Q2 2026 were $16.59M, a decrease of -22.83% from the previous quarter. DE:C970 total liabilities were $3.88M for the fiscal quarter, a -28.93% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.